Amundi Asset Management US’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$844M Sell
5,132,665
-11,790
-0.2% -$1.91M 0.65% 25
2020
Q4
$810M Sell
5,144,455
-938,593
-15% -$139M 0.69% 25
2020
Q3
$906M Buy
6,083,048
+158,794
+3% +$23.5M 0.95% 16
2020
Q2
$833M Buy
5,924,254
+726,526
+14% +$106M 0.99% 15
2020
Q1
$682M Buy
5,197,728
+472,064
+10% +$67M 1.19% 12
2019
Q4
$689M Buy
4,725,664
+2,061,958
+77% +$280M 0.81% 17
2019
Q3
$345M Buy
2,663,706
+8,310
+0.3% +$1.09M 0.51% 36
2019
Q2
$370M Sell
2,655,396
-299,174
-10% -$41.4M 0.3% 90
2019
Q1
$413M Sell
2,954,570
-1,698,310
-37% -$227M 0.58% 33
2018
Q4
$600M Sell
4,652,880
-111,752
-2% -$15.6M 0.55% 21
2018
Q3
$658M Buy
4,764,632
+240,629
+5% +$32M 0.86% 15
2018
Q2
$549M Buy
4,524,003
+394,635
+10% +$49.2M 0.79% 18
2018
Q1
$529M Sell
4,129,368
-589,885
-12% -$79.7M 0.85% 17
2017
Q4
$659M Buy
4,719,253
+2,495,420
+112% +$348M 1.02% 11
2017
Q3
$289M Sell
2,223,833
-45,359
-2% -$6.01M 0.92% 29
2017
Q2
$300M Buy
2,269,192
+58,785
+3% +$7.5M 0.98% 23
2017
Q1
$275M Sell
2,210,407
-2,619,920
-54% -$313M 0.93% 26
2016
Q4
$557M Buy
4,830,327
+1,375,658
+40% +$159M 1.96% 6
2016
Q3
$408M Buy
3,454,669
+230,812
+7% +$28M 1.47% 13
2016
Q2
$391M Sell
3,223,857
-451,478
-12% -$51.3M 1.42% 12
2016
Q1
$398M Sell
3,675,335
-148,839
-4% -$15.4M 1.48% 8
2015
Q4
$393M Buy
3,824,174
+1,442,984
+61% +$145M 1.47% 8
2015
Q3
$222M Buy
2,381,190
+312,924
+15% +$30.3M 0.91% 23
2015
Q2
$202M Sell
2,068,266
-554,527
-21% -$55.5M 0.74% 27
2015
Q1
$264M Sell
2,622,793
-99,576
-4% -$10.1M 0.94% 17
2014
Q4
$285M Sell
2,722,369
-1,480,313
-35% -$156M 1.03% 12
2014
Q3
$448M Sell
4,202,682
-126,852
-3% -$13.2M 1.69% 3
2014
Q2
$453M Buy
4,329,534
+438,161
+11% +$44.3M 1.74% 3
2014
Q1
$382M Sell
3,891,373
-122,370
-3% -$11.3M 1.46% 5
2013
Q4
$368M Buy
4,013,743
+134,028
+3% +$12.4M 1.41% 6
2013
Q3
$336M Sell
3,879,715
-361,792
-9% -$32.5M 1.36% 6
2013
Q2
$364M Buy
+4,241,507
New +$360M 1.52% 3

Other funds holding JNJ

Amundi Asset Management US's JNJ Position: Q1 2021 in Review

Amundi Asset Management US reduced its Johnson & Johnson (JNJ) stake by 0.23% in Q1 2021, selling an estimated $1.91M and leaving 5,132,665 shares worth $844M. The position accounts for 0.65% of the portfolio, ranked #25.

Amundi Asset Management US first reported a position in JNJ in Q2 2013 and has held it in 32 quarters since. The position peaked at $906M in Q3 2020. 3,317 funds tracked by Wall St. Rank hold JNJ as of Q1 2021.

  • Amundi Asset Management US held 5,132,665 shares of Johnson & Johnson worth $844M as of Q1 2021.
  • Amundi Asset Management US sold 11,790 Johnson & Johnson shares in Q1 2021, an estimated $1.91M.
  • Johnson & Johnson made up 0.65% of Amundi Asset Management US's portfolio in Q1 2021, its #25 holding.
  • Amundi Asset Management US first reported a position in Johnson & Johnson in Q2 2013 and has held it in 32 quarters since.
  • Amundi Asset Management US's Johnson & Johnson position peaked at $906M in Q3 2020.
  • 3,317 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.